We are live on ! Find out more
AIM

Alerce Investment Management Portfolio holdings

AUM $56.8M
1-Year Est. Return 31.17%
This Fund
S&P 500
This Quarter Est. Return
+7.57%
1 Year Est. Return
+31.17%
3 Year Est. Return
+25.12%
5 Year Est. Return
10 Year Est. Return
AUM
$76.9M
AUM Growth
+$1.19M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
6
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ANNX icon
1
Annexon
ANNX
$834M
$24.8M 32.31%
7,056,024
AMWL icon
2
American Well
AMWL
$180M
$22M 28.62%
523,786
AKBA icon
3
Akebia Therapeutics
AKBA
$354M
$14.8M 19.29%
16,205,119
WHWK
4
Whitehawk Therapeutics
WHWK
$190M
$11.2M 14.51%
1,630,830
ASMB icon
5
Assembly Biosciences
ASMB
$498M
$2.56M 3.33%
185,625
RNTX
6
Rein Therapeutics
RNTX
$63.1M
$1.49M 1.93%
830,466

Similar funds

Alerce Investment Management's Q2 2023 Portfolio in Review

As of Q2 2023, Alerce Investment Management held 6 positions worth $76.9M, up 1.6% from $75.7M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2023: portfolio turnover was 0%. Alerce Investment Management opened no new positions and made no exits, leaving the 6-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Alerce Investment Management's ten largest holdings make up 100% of its $76.9M portfolio in Q2 2023.
  • Alerce Investment Management opened 0 new positions and closed 0 in Q2 2023.
  • Alerce Investment Management's portfolio value rose 1.6% quarter-over-quarter to $76.9M.

Based on Alerce Investment Management's 13F filing for Q2 2023, filed 14 Aug 2023.